Publication | Closed Access

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long–Evans Tokushima fatty rats

InflammationMetabolic SyndromeSodium–glucose Cotransporter 2FibrosisLiver FibrosisMedicineLiver PhysiologyPhysiologyDiabetesPathologyHepatology FibrosisFatty Liver DiseasePharmacologyHealth Sciences